<DOC>
	<DOCNO>NCT00314054</DOCNO>
	<brief_summary>The purpose study ass pharmacokinetics ( PK ) HCV-796 subject chronic hepatic impairment match healthy adult .</brief_summary>
	<brief_title>Study Evaluating Safety HCV-796 Subjects With Liver Disease Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<criteria>Men woman nonchildbearing potential . Hepatic impairment subject : ChildPugh class A , B , C accord CP classification base history , physical examination , laboratory test result . Healthy volunteer : healthy determine investigator . History alcoholism within 1 year . Hepatic impairment subject : evidence unstable clinically significant disease impair hepatic function . Healthy volunteer : positive serologic finding hepatitis B surface antigen ( HBsAg ) and/or hepatitis C virus ( HCV ) antibody .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Hepatic Impairment</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Hepacivirus</keyword>
</DOC>